CD8A and nonpapillary renal cell carcinoma: Results of experimental study done by Chevrier et al.14 show that macrophages are the most frequent immune cells in most ccRCC tumors with a mean of 31% followed by CD8+ T-cells and CD4+ T-cells, respectively (H), which are in agreement with the results of CIBERSORTx applied on TCGA data set (Fig. 1C,I).